Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News MGM RESORTS INTERNATIONAL MGM

MGM Resorts International, through its subsidiaries, operates as a gaming and entertainment company in the United States, China, and internationally. The company operates through four segments: Las Vegas Strip Resorts, Regional Operations, MGM China, and MGM Digital. It operates casino resorts that offer gaming, hotel, convention, dining, entertainment, retail, and other resort amenities, as... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Opinion & Analysis (NYSE:MGM)

Casino ETF Keeps Landing On Red

Benzinga.com  September 17, 2014

Bullboard Posts (NYSE:MGM)

This is Going to Change Society: Kevin Harrington Speaks

This is the very exciting part! A breakthrough product!<< View Post To Watch Video >>
Peng26 - April 13, 2023

Kevin Harrington Discusses FSD Pharma

<< View Post To Watch Video >> I believe this new product will aid society in reducing the number of alcohol-related...
KarenCar - April 13, 2023

FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent

 
KarenCar - July 14, 2022

FSD Will Proceed with Phase2 of FSD-201 Soon After Clearance

<< View Post To Watch Video >> FSD Pharma ready to proceed with Phase 2 clinical trial of FSD-201 as soon as it gets...
KarenCar - June 3, 2022

FSD Pharma Files Investigational New Drug Application “IND”

KarenCar - June 1, 2022

FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets

 
KarenCar - May 10, 2022